CONTINUING EDUCATION INFORMATION This continuing medical education activity is certified for up to 10.25 AMA PRA Category 1 Credits™. Sponsor Provided by the Academy for Healthcare Education, Inc. Grantor This continuing medical education activity is supported by an unrestricted educational grant from Eisai Inc. Target Audience This educational activity will be of value to primary care physicians, psychiatrists, neurologists, as well as nurse practitioners and physician assistants who are involved in providing care to patients with Alzheimer’s disease (AD) and related dementias. Learning Objectives Following this activity, participants should be better able to Outline the current and projected epidemiologic and financial impact of AD and related dementias in the United States Review effective techniques for diagnosing AD and differentiate AD from other conditions that cause dementia Evaluate pharmacologic and nonpharmacologic treatments for dementia and dementia-related neuropsychiatric symptoms Discuss the advances in imaging, biomarkers, and other techniques to improve the diagnosis and monitoring of dementia Describe the current understanding of the pathophysiology of AD and other geriatric syndromes and discuss how this affects the development of new therapeutic options Identify the currently recognized risk factors for dementia and ongoing research efforts for dementia prevention Appropriately incorporate what they have learned into the care of patients Accreditation The Academy for Healthcare, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. AMA PRA Category 1 Credit™ The Academy for Healthcare Education, Inc., designates this educational activity for a maximum of 10.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. AANP This educational activity is pending approval by the American Academy of Nurse Practitioners. AAPA AAPA accepts Category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by ACCME. Read our Disclaimer.